Parkway Medical Center

Parkway Medical Center is a clinical research site and multi-specialty medical practice based in Birmingham, Alabama, that specializes in conducting Phase 2 and Phase 3 clinical trials for the pharmaceutical and biotechnology industries. Led by Medical Director Dr. Gregory Sullivan, the center has served as a prominent investigative site for numerous high-profile drug development programs, including those for cardiovascular disease, metabolic disorders, and addiction medicine. The facility is recognized for its contributions to the clinical validation of therapies such as pelacarsen (Novartis) and the FDA-approved opioid dependence treatment BUNAVAIL (BioDelivery Sciences). Parkway Medical Center partners with major industry players like Novartis, Eli Lilly, and Bayer to advance novel therapeutics through the clinical pipeline. The center's expertise spans a wide range of therapeutic areas, including cardiology, endocrinology, and infectious diseases.